from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2619c/-

LFCtreatmentdescriptionclass of inhibitor

-0.118

Amikacinug/mL Amikacintranslation

-0.466

Cap5-10ug/mL Capreomycintranslation

-0.745

Rox10-50 ug/mL Roxithromycintranslation

-0.590

SM2-5 ug/mL Streptomycintranslation

-0.660

Tet5-10 ug/mL Tetracyclinetranslation

0.172

Rif0.2-5ug/mL Rifampicintranscription

1.369

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.148

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.566

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.298

CPZ10-50 ug/mL Chlorpromazinerespiration

0.081

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.382

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.210

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.395

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.791

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.505

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.209

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.439

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

6.372

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.759

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.914

KCN5-20 ug/mL Potassium cyaniderespiration

-0.306

NaN30.2-2 mM Sodium aziderespiration

-0.931

Nigericin50 uM Nigericinrespiration

0.485

TRC10-150 ug/mL Triclosanrespiration

1.472

TRZ10-25 ug/mL Thioridazinerespiration

0.076

Valinomycin0.5-10 uM Valinomycinrespiration

-1.633

ZnSO42 mM ZnSO4respiration

0.096

menadione6-10 ug/mL Menadionerespiration

-0.462

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.453

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.191

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.138

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.339

NRP_1Non-replicating persistence stage 1dosRassociated

-0.413

Amp0.2mg/mL AmpicillincellWall

-0.346

Cephalexin20-100 ug/mL CephalexincellWall

-0.445

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.710

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.648

EMB10-20 ug/mL EthambutolcellWall

-0.789

Eta12-40 ug/mL EthionamidecellWall

-1.058

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.083

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.478

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.602

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.264

BZA0.12 mg/mL BenzamidearomaticAmides

0.206

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.336

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.116

H2O24 mM hydrogen peroxideDNAdamaging

-0.081

Levo10 ug/mL LevofloxacinDNAdamaging

0.093

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.498

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.288

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.170

UVUV-irradiationDNAdamaging

1.134

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.157

Antimycin12.5-50 ug/mL Antimycin A?

-0.413

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.118

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.222

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.272

PA8240.2-2 ug/mL PA-824?

-0.062

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.343

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.335

Verapamil50 uM Verapamil?

-0.077

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.870

methoxatin10-20 ug/mL Methoxatin?